We found that VGF levels were also increased in people with relapsing-remitting MS (pwRRMS) during remission (Figure 3E, measurements of all individual peptides are shown in Supplemental Figure 3B; cohort characteristics are provided in Supplemental Table 3). This evidence concerns the gene VGF and relapsing-remitting multiple sclerosis.